Overview

GSK1349572 Drug Interaction Study With Protease Inhibitors

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
A study in healthy volunteers to determine whether there is a drug interaction between GSK1349572 and the HIV protease inhibitors lopinavir/ritonavir and darunavir/ritonavir
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Collaborator:
Shionogi
Treatments:
Darunavir
Dolutegravir
Lopinavir
Protease Inhibitors
Ritonavir